ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN
MTUL
1 hedge funds and large institutions have $16 invested in ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
1.09% less ownership
Funds ownership: 1.09% → 0% (-1.1%)
100% less capital invested
Capital invested by funds: $165K → $16 (-$165K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$168K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $16 | -$168K | -10,879 | -100% |
|
MTUL Hedge Fund Activity: Q2 2023 in Review
1 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) for Q2 2023, worth a combined $16 — down 100% from $165K a quarter earlier.
Fund positioning in MTUL was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $168K.
- 1 institutional investor held ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $16 of ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN positions in Q2 2023 and 0 closed out.
- The largest ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN seller in Q2 2023 was UBS Group, an estimated $168K sold.
Based on aggregated 13F filings for Q2 2023.